Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients.

导出 LinkOut

翻译打印收藏纠错

作者： Juan,Macías ^[1] ; Karin,Neukam ; Josep,Mallolas ; Luis F,López-Cortés ; José A,Cartón ; Pere,Domingo ; Santiago,Moreno ; José A,Iribarren ; Bonaventura,Clotet ; Manell,Crespo ; Ignacio,de Los Santos ; Enrique,Ortega ; Hernando,Knobel ; María J,Jiménez-Expósito ; Juan A,Pineda ; COINS Study Team

作者单位： Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain. ^[1]

主题词成年人(Adult);抗HIV药(Anti-HIV Agents);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);HIV感染(HIV Infections);丙型肝炎(Hepatitis C);人类(Humans);男(雄)性(Male);中年人(Middle Aged);比值比(Odds Ratio);回顾性研究(Retrospective Studies);危险因素(Risk Factors);利托纳韦(Ritonavir)

DOI 10.1310/hct1302-61

PMID 22510353

发布时间 2016-11-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览8

HIV clinical trials

61-9页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients.

HIV clinical trials

相似文献

HIV clinical trials

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients.

HIV clinical trials

相似文献

HIV clinical trials

相关期刊

检索历史清除